V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210003723 | 210013005 | 1.55 | 67.85 | Neo-adjuvant (N) | 2020-01-12 | 2020-01-26 | TCH (21 day Trastuzumab) Maint | 02 | N | CARBOPLATIN + GEMCITABINE | 100832036 |
| 210003725 | 210013006 | 1.71 | 57.7 | Palliative (P) | 2017-12-07 | 2017-12-09 | Paclitaxel+Trastuzumab wkly Maint | null | N | PACLITAXEL + TRASTUZUMAB | 100388097 |
| 210003727 | 210013007 | null | 74 | Neo-adjuvant (N) | null | 2018-11-14 | null | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101141121 |
| 210003728 | 210013008 | null | null | Neo-adjuvant (N) | 2018-08-07 | 2018-10-28 | null | null | N | FEC + DOCETAXEL | 100605706 |
| 210003729 | 210013009 | 1.73 | 85.3 | Palliative (P) | 2020-04-05 | 2020-04-15 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 100347717 |
| 210003741 | 210013013 | 1.63 | 109.9 | Neo-adjuvant (N) | null | 2018-04-10 | Letrozole + Palbociclib | 02 | N | CYCLOPHOSPHAMIDE + DOCETAXEL | 100738148 |
| 210003743 | 210013015 | 1.68 | 92 | Neo-adjuvant (N) | null | 2019-10-25 | null | null | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100196066 |
| 210003749 | 210013017 | null | 57.3 | null | null | 2020-12-30 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 101397605 |
| 210003750 | 210013018 | 1.67 | 67.85 | null | 2021-12-17 | 2022-04-02 | Capecitabine | 02 | null | CAPECITABINE | 101617762 |
| 210003751 | 210013019 | 1.76 | 62.6 | null | 2021-01-30 | 2021-04-13 | CARBOPLATIN | 02 | null | CARBOPLATIN | 101566613 |
| 210003753 | 210013020 | 1.67 | 68.4 | null | null | 2021-12-04 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100556658 |
| 210003754 | 210013021 | null | null | null | 2020-03-15 | 2020-04-05 | CARBOPLATIN + DOCETAXEL + Pertuzumab + Trastuzumab | N | null | ATEZOLIZUMAB + NAB-PACLITAXEL | 100575774 |
| 210003755 | 210013022 | 1.64 | 58.5 | Neo-adjuvant (N) | 2015-10-08 | 2018-05-10 | CARBOPLATIN + PACLITAXEL | 02 | N | BLEOMYCIN | 100206801 |
| 210003762 | 210013023 | 1.58 | 84 | null | 2018-06-25 | 2018-06-27 | Everolimus 10mg | null | null | LETROZOLE + PALBOCICLIB | 101823616 |
| 210003767 | 210013024 | 1.77 | 77.7 | null | 2020-07-31 | 2020-10-08 | null | 02 | null | LETROZOLE + PALBOCICLIB | 100759298 |
| 210003776 | 210013028 | 1.61 | 57.7 | Adjuvant (A) | 2021-05-11 | 2021-10-01 | Cyclophosphamide+Doce+Tras Main | 02 | N | CAPECITABINE | 100501252 |
| 210003783 | 210013033 | 1.46 | 60 | Palliative (P) | 2021-06-09 | 2021-07-07 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 100235204 |
| 210003790 | 210013034 | null | 0 | null | 2019-11-11 | 2019-11-13 | FEC 100 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101234165 |
| 210003792 | 210013035 | 0 | 78 | null | 2021-03-01 | 2021-03-10 | FEC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100133076 |
| 210003794 | 210013036 | 1.59 | 57.6 | null | null | 2020-04-28 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101774771 |
| 210003796 | 210013037 | 1.6 | 82.7 | Adjuvant (A) | 2021-11-26 | 2021-12-14 | Paclitaxel+Trastuzumab wkly Maint | 02 | N | PACLITAXEL + TRASTUZUMAB | 100395150 |
| 210003797 | 210013038 | 1.73 | 82.5 | null | 2020-02-08 | 2020-05-24 | TRANSPLANT MELPHALAN AUTOLOGOUS | null | null | EC | 100216251 |
| 210003803 | 210013040 | 1.63 | 66.3 | Palliative (P) | 2020-10-26 | 2021-06-01 | Hydroxycarbamide | 02 | N | CARBOPLATIN + PACLITAXEL | 100784792 |
| 210003805 | 210013041 | 1.56 | 68.8 | Palliative (P) | 2020-03-13 | 2020-03-14 | GemCarbo Days 1+8 | N | N | CARBOPLATIN + GEMCITABINE | 100072693 |
| 210003808 | 210013043 | 1.69 | 55.3 | null | null | 2020-03-03 | null | 02 | null | ABEMACICLIB + FULVESTRANT | 100749803 |
| 210003809 | 210013044 | 1.57 | 65 | null | 2020-12-15 | 2020-12-18 | Trial Unspecified | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 101688181 |
| 210003811 | 210013045 | 1.73 | 76.4 | null | null | 2017-02-16 | Letrozole + Palbociclib | 02 | null | NAB-PACLITAXEL | 100844377 |
| 210003818 | 210013048 | 1.65 | 70 | Palliative (P) | 2020-08-10 | 2020-08-24 | EC | 02 | N | CARBOPLATIN + PACLITAXEL | 101420244 |
| 210003822 | 210013051 | null | null | null | 2020-07-19 | 2020-12-05 | TCH (21 day Trastuzumab) Maint | 02 | null | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 100568439 |
| 210003826 | 210013053 | 1.71 | null | Palliative (P) | 2020-08-13 | 2020-09-15 | PERTUZUMAB + TRASTUZUMAB | 02 | N | PERTUZUMAB + TRASTUZUMAB | 101339951 |
| 210003830 | 210013055 | 1.6 | 88.1 | Neo-adjuvant (N) | 2019-01-01 | 2019-01-09 | Carboplatin + Docetaxel | 02 | N | FULVESTRANT + PALBOCICLIB | 101383942 |
| 210003832 | 210013056 | 1.69 | 59.5 | Palliative (P) | 2019-08-29 | 2019-09-28 | ATEZOLIZUMAB + NAB PACLITAXEL | 02 | N | PALBOCICLIB | 100586130 |
| 210003834 | 210013057 | 1.61 | 98.1 | Palliative (P) | 2019-06-18 | 2019-08-21 | null | null | N | PALBOCICLIB | 100149178 |
| 210003844 | 210013059 | 1.71 | 132.4 | Neo-adjuvant (N) | 2021-04-04 | 2021-10-19 | null | 02 | N | LETROZOLE + PALBOCICLIB | 100348651 |
| 210003845 | 210013060 | 1.75 | 57.4 | Palliative (P) | 2018-11-06 | 2022-01-15 | null | 02 | N | PALBOCICLIB | 100474186 |
| 210003846 | 210013061 | 1.63 | 67.3 | Palliative (P) | 2017-04-01 | 2017-04-01 | PERTUZUMAB | 02 | N | PERTUZUMAB | 101408426 |
| 210003848 | 210013062 | 1.67 | 100.3 | null | 2019-08-25 | 2019-08-27 | Pertuzumab (Loading) | 02 | null | PERTUZUMAB | 100349970 |
| 210003852 | 210013066 | 1.65 | 53.6 | null | 2016-09-24 | 2019-06-05 | PERTUZUMAB + TRASTUZUMAB | 02 | null | PERTUZUMAB + TRASTUZUMAB | 100647356 |
| 210003857 | 210013067 | 1.81 | 55.45 | null | 2020-10-28 | 2020-11-17 | null | 02 | null | CAPECITABINE | 100064061 |
| 210003858 | 210013068 | null | null | null | null | 2016-12-17 | TCH (21 day Trastuzumab) Maint | 02 | null | LETROZOLE + PALBOCICLIB | 101594501 |
| 210003859 | 210013069 | 1.59 | 63.8 | Adjuvant (A) | 2017-06-07 | 2020-04-20 | Capecitabine | null | N | CAPECITABINE | 100934002 |
| 210003864 | 210013071 | 1.62 | 73.6 | Palliative (P) | 2019-11-17 | 2019-12-17 | Capecitabine | 02 | N | CAPECITABINE | 100309071 |
| 210003872 | 210013074 | 1.54 | 58.7 | null | 2021-08-01 | 2021-10-26 | FEC 100 | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100048535 |
| 210003876 | 210013076 | null | null | null | 2020-04-06 | 2020-04-06 | Capecitabine | 02 | null | CAPECITABINE | 100468627 |
| 210003879 | 210013078 | 1.63 | 96 | null | 2021-12-25 | 2021-12-31 | null | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100017528 |
| 210000349 | 210013083 | 1.58 | 85 | Adjuvant (A) | null | 2020-04-24 | EC | 01 | N | EC | 100771838 |
| 210000406 | 210013084 | 0 | 72.75 | null | 2021-07-17 | 2021-11-03 | Letrozole + Palbociclib | 02 | null | EC | 101185927 |
| 210000730 | 210013085 | 1.54 | 88.3 | null | 2019-12-24 | 2019-12-24 | Paclitaxel+Trastuzumab wkly Maint | null | null | PACLITAXEL + TRASTUZUMAB | 100737972 |
| 210000828 | 210013086 | 1.57 | 82.5 | Neo-adjuvant (N) | 2021-05-10 | 2021-05-10 | EC | 02 | N | EC | 101773283 |
| 210001086 | 210013088 | 1.68 | 77.8 | null | 2021-10-21 | 2021-11-13 | Vinorelbine (oral) | 02 | null | VINORELBINE | 101663547 |